Healthtech Series B Investors & VC Firms
1028 firms in this list, with a median first check of $540K. 256 of them lead rounds. Generated from verified public data and updated continuously.
Aisling Capital
New YorkSeed–Series C
12 people
Advent Life Sciences
LondonSeed–Series C
28 people
Two Sigma Ventures
New YorkSeed–Series B$2M – $15M
26 people
Kfund
MadridPre-Seed–Series B$108K – $10.8M
27 people
Maverick Ventures
San FranciscoSeed–Series B$3M – $10M
10 people
Gresham House Ventures
LondonSeed–Growth$1.3M – $26M
38 people
Vertex Ventures Israel
Tel Aviv-YafoSeed–Series B$1M – $10M
17 people
SR One Capital Management
Redwood CitySeed–Series B
30 people
Palatine
ManchesterSeries B–Growth
43 people
OMERS Ventures
TorontoPre-Seed–Series C$5M – $25M
15 people
S3 Ventures
AustinSeed–Series B$500K – $15M
12 people
aMoon
Ra'ananaSeed–Late Stage
33 people
Hitachi Ventures
MunichSeed–Growth
32 people
Legend Capital
BeijingSeed–Series C$2M – $10M
28 people
Vensana Capital
MinneapolisSeries A–Late Stage
43 people
GreatPoint Ventures
San FranciscoSeed–Series B$250K – $20M
15 people
Supernova Invest
ParisSeed–Growth
34 people
Alteria Capital
MumbaiSeries A–Growth
28 people
Kibo Ventures
MadridSeed–Series B$2.2M – $5.4M
31 people
Sandbox Industries
ChicagoSeed–Growth
34 people
Geodesic Capital
Silicon ValleySeed–Growth
29 people
Investinor
TrondheimPre-Seed–Growth
43 people
RiverVest Venture Partners
St. LouisSeed–Series C$500K – $3M
23 people
MassMutual Ventures
SpringfieldSeed–Series B$500K – $5M
13 people
Related lists
Healthtech Investors & VC Firms (4191)Healthtech Seed Investors & VC Firms (3233)Series B Investors & VC Firms (2946)Healthtech Investors & VC Firms in North America (2666)Healthtech Investors & VC Firms in United States (2437)Healthtech Series A Investors & VC Firms (2310)Series B Investors & VC Firms in North America (1736)Series B Investors & VC Firms in United States (1571)Healthtech Pre-Seed Investors & VC Firms (1468)Healthtech Investors & VC Firms in Europe (1358)
Data sourced from public filings and firms' own websites — see our methodology.

















































































































